カテゴリー： 世界, 医療/バイオ, Transparency Market Research

世界のオルソバイオロジクス市場2023-2031：製品別（同種移植片、異種移植片、合成骨移植片、脱灰骨マトリックス、内臓補填剤、血小板豊富血漿、骨髄吸引濃縮液、その他）

【英語タイトル】Orthobiologics Market (Product: Allografts, Xenografts, Synthetic Bone Grafts, Demineralized Bone Matrix, Viscosupplementation, Platelet-rich Plasma, Bone Marrow Aspirate Concentrate, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが出版した調査資料（TMR23JUL097）・商品コード：TMR23JUL097
・発行会社（調査会社）：Transparency Market Research
・発行日：2023年4月
・ページ数：237
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートは、世界のオルソバイオロジクス市場規模が、2023年の84億ドルから予測期間中、年平均5.5％で成長し、2031年には138億ドルに達すると予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（同種移植片、異種移植片、合成骨移植片、脱灰骨マトリックス、その他）分析、用途別（脊椎固定術、外傷修復、再建手術、骨折、その他）分析、エンドユーザー別（病院、整形外科クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを整理しています。なお、当市場の主要企業には、Alphatec Spine, Inc.、Arthrex、Bioventus LLC、Exactech, Inc.、Global Medical, Inc.、Integra Lifesciences、Medtronic、MTF Biologics、RTI Surgical、Sano Orthopedics、Sanofi、Seikagaku Corporation、Stryker、Zimmer Biometなどが含まれています。
・序論
・仮定＆調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のオルソバイオロジクス市場規模：製品別
- 同種移植片の市場規模
- 異種移植片の市場規模
- 合成骨移植片の市場規模
- 脱灰骨マトリックスの市場規模
- その他製品の市場規模
・世界のオルソバイオロジクス市場規模：用途別
- 脊椎固定術における市場規模
- 外傷修復における市場規模
- 再建手術における市場規模
- 骨折における市場規模
- その他用途における市場規模
・世界のオルソバイオロジクス市場規模：エンドユーザー別
- 病院における市場規模
- 整形外科クリニックにおける市場規模
- その他エンドユーザーにおける市場規模
・世界のオルソバイオロジクス市場規模：地域別
- 北米のオルソバイオロジクス市場規模
- ヨーロッパのオルソバイオロジクス市場規模
- アジア太平洋のオルソバイオロジクス市場規模
- 中南米のオルソバイオロジクス市場規模
- 中東・アフリカのオルソバイオロジクス市場規模
・競争状況

Orthobiologics Market – Scope of Report
TMR’s report on the global Orthobiologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Orthobiologics Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Orthobiologics Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasmonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.

The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the global Orthobiologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Orthobiologics Market profiled in this report.

Key Questions Answered in Global Orthobiologics Market Report
• What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
• What are the opportunities in the global Plasmonic Materials market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Orthobiologics Market – Research Objectives and Research Approach
The comprehensive report on the global Orthobiologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Orthobiologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.
”

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Orthobiologics Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Key Market Trends
    5.2. Merger & Acquisition
    5.3. Strategies of Top Five Players Operating in the Market
    5.4. Incidence of Orthopedic Disorder, by Key Countries
    5.5. Number of Surgical Procedures
    5.6. Regulatory and Reimbursement Scenario by Key Countries
    5.7. Covid-19 Pandemic Impact on the Industry
6. Global Orthobiologics Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product, 2017-2031
        6.3.1. Allografts
        6.3.2. Xenografts
        6.3.3. Synthetic Bone Grafts
            6.3.3.1. Hydroxyapatite
            6.3.3.2. β-tricalcium Phosphate (β-TCP)
            6.3.3.3. BiPhasic
            6.3.3.4. Bioactive Glass
            6.3.3.5. Others
        6.3.4. Demineralized Bone Matrix (DBM)
        6.3.5. Viscosupplementation
        6.3.6. Platelet-rich Plasma (PRP)
        6.3.7. Bone Marrow Aspirate Concentrate (BMAC)
        6.3.8. Others
    6.4. Market Attractiveness Analysis, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017-2031
        7.3.1. Spinal Fusion
        7.3.2. Trauma Repair
        7.3.3. Reconstructive Surgeries
        7.3.4. Fractures
        7.3.5. Osteoarthritis
        7.3.6. Maxillofacial & Dental Applications
        7.3.7. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017-2031
        8.3.1. Hospitals
        8.3.2. Orthopedic Clinics
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Orthobiologics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017-2031
        10.2.1. Allografts
        10.2.2. Xenografts
        10.2.3. Synthetic Bone Grafts
            10.2.3.1. Hydroxyapatite
            10.2.3.2. β-tricalcium Phosphate (β-TCP)
            10.2.3.3. BiPhasic
            10.2.3.4. Bioactive Glass
            10.2.3.5. Others
        10.2.4. Demineralized Bone Matrix (DBM)
        10.2.5. Viscosupplementation
        10.2.6. Platelet-rich Plasma (PRP)
        10.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        10.2.8. Others
    10.3. Market Value Forecast, by Application, 2017-2031
        10.3.1. Spinal Fusion
        10.3.2. Trauma Repair
        10.3.3. Reconstructive Surgeries
        10.3.4. Fractures
        10.3.5. Osteoarthritis
        10.3.6. Maxillofacial & Dental Applications
        10.3.7. Others
    10.4. Market Value Forecast, by End-user, 2017-2031
        10.4.1. Hospitals
        10.4.2. Orthopedic Clinics
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017-2031
        11.2.1. Allografts
        11.2.2. Xenografts
        11.2.3. Synthetic Bone Grafts
            11.2.3.1. Hydroxyapatite
            11.2.3.2. β-tricalcium Phosphate (β-TCP)
            11.2.3.3. BiPhasic
            11.2.3.4. Bioactive Glass
            11.2.3.5. Others
        11.2.4. Demineralized Bone Matrix (DBM)
        11.2.5. Viscosupplementation
        11.2.6. Platelet-rich Plasma (PRP)
        11.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        11.2.8. Others
    11.3. Market Value Forecast, by Application, 2017-2031
        11.3.1. Spinal Fusion
        11.3.2. Trauma Repair
        11.3.3. Reconstructive Surgeries
        11.3.4. Fractures
        11.3.5. Osteoarthritis
        11.3.6. Maxillofacial & Dental Applications
        11.3.7. Others
    11.4. Market Value Forecast, by End-user, 2017-2031
        11.4.1. Hospitals
        11.4.2. Orthopedic Clinics
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017-2031
        12.2.1. Allografts
        12.2.2. Xenografts
        12.2.3. Synthetic Bone Grafts
            12.2.3.1. Hydroxyapatite
            12.2.3.2. β-tricalcium Phosphate (β-TCP)
            12.2.3.3. BiPhasic
            12.2.3.4. Bioactive Glass
            12.2.3.5. Others
        12.2.4. Demineralized Bone Matrix (DBM)
        12.2.5. Viscosupplementation
        12.2.6. Platelet-rich Plasma (PRP)
        12.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        12.2.8. Others
    12.3. Market Value Forecast, by Application, 2017-2031
        12.3.1. Spinal Fusion
        12.3.2. Trauma Repair
        12.3.3. Reconstructive Surgeries
        12.3.4. Fractures
        12.3.5. Osteoarthritis
        12.3.6. Maxillofacial & Dental Applications
        12.3.7. Others
    12.4. Market Value Forecast, by End-user, 2017-2031
        12.4.1. Hospitals
        12.4.2. Orthopedic Clinics
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017-2031
        13.2.1. Allografts
        13.2.2. Xenografts
        13.2.3. Synthetic Bone Grafts
            13.2.3.1. Hydroxyapatite
            13.2.3.2. β-tricalcium Phosphate (β-TCP)
            13.2.3.3. BiPhasic
            13.2.3.4. Bioactive Glass
            13.2.3.5. Others
        13.2.4. Demineralized Bone Matrix (DBM)
        13.2.5. Viscosupplementation
        13.2.6. Platelet-rich Plasma (PRP)
        13.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        13.2.8. Others
    13.3. Market Value Forecast, by Application, 2017-2031
        13.3.1. Spinal Fusion
        13.3.2. Trauma Repair
        13.3.3. Reconstructive Surgeries
        13.3.4. Fractures
        13.3.5. Osteoarthritis
        13.3.6. Maxillofacial & Dental Applications
        13.3.7. Others
    13.4. Market Value Forecast, by End-user, 2017-2031
        13.4.1. Hospitals
        13.4.2. Orthopedic Clinics
        13.4.3. Others
    13.5. Market Value Forecast, by Country, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017-2031
        14.2.1. Allografts
        14.2.2. Xenografts
        14.2.3. Synthetic Bone Grafts
            14.2.3.1. Hydroxyapatite
            14.2.3.2. β-tricalcium Phosphate (β-TCP)
            14.2.3.3. BiPhasic
            14.2.3.4. Bioactive Glass
            14.2.3.5. Others
        14.2.4. Demineralized Bone Matrix (DBM)
        14.2.5. Viscosupplementation
        14.2.6. Platelet-rich Plasma (PRP)
        14.2.7. Bone Marrow Aspirate Concentrate (BMAC)
        14.2.8. Others
    14.3. Market Value Forecast, by Application, 2017-2031
        14.3.1. Spinal Fusion
        14.3.2. Trauma Repair
        14.3.3. Reconstructive Surgeries
        14.3.4. Fractures
        14.3.5. Osteoarthritis
        14.3.6. Maxillofacial & Dental Applications
        14.3.7. Others
    14.4. Market Value Forecast, by End-user, 2017-2031
        14.4.1. Hospitals
        14.4.2. Orthopedic Clinics
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share/Ranking Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. Alphatec Spine, Inc.
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Strategic Overview
        15.3.2. Arthrex
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Strategic Overview
        15.3.3. Bioventus LLC
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Strategic Overview
        15.3.4. Exactech, Inc.
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Strategic Overview
        15.3.5. Global Medical, Inc.
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Strategic Overview
        15.3.6. Integra Lifesciences
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
            15.3.6.4. Strategic Overview
        15.3.7. Medtronic
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
            15.3.7.4. Strategic Overview
        15.3.8. MTF Biologics
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Strategic Overview
        15.3.9. RTI Surgical
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Strategic Overview
        15.3.10. Sano Orthopedics
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Strategic Overview
        15.3.11. Sanofi
            15.3.11.1. Company Overview
            15.3.11.2. Product Portfolio
            15.3.11.3. SWOT Analysis
            15.3.11.4. Strategic Overview
        15.3.12. Seikagaku Corporation
            15.3.12.1. Company Overview
            15.3.12.2. Product Portfolio
            15.3.12.3. SWOT Analysis
            15.3.12.4. Strategic Overview
        15.3.13. Stryker
            15.3.13.1. Company Overview
            15.3.13.2. Product Portfolio
            15.3.13.3. SWOT Analysis
            15.3.13.4. Strategic Overview
        15.3.14. Zimmer Biomet
            15.3.14.1. Company Overview
            15.3.14.2. Product Portfolio
            15.3.14.3. SWOT Analysis
            15.3.14.4. Strategic Overview

List of Tables

Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by 2017‒2031, by Application

Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Orthobiologics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 07: North America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 08: North America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 15: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 16: Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 19: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 20: Latin America Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017‒2031

Table 23: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 24: Middle East & Africa Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

★調査レポート[世界のオルソバイオロジクス市場2023-2031：製品別（同種移植片、異種移植片、合成骨移植片、脱灰骨マトリックス、内臓補填剤、血小板豊富血漿、骨髄吸引濃縮液、その他）] (コード：TMR23JUL097)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオルソバイオロジクス市場2023-2031：製品別（同種移植片、異種移植片、合成骨移植片、脱灰骨マトリックス、内臓補填剤、血小板豊富血漿、骨髄吸引濃縮液、その他）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の骨移植代替物市場（～2030年）：製品別（同種移植片、異種移植片、合成骨移植片、機械加工同種移植片、自家移植片、その他）、材料別（ポリマー、ヒドロキシパプタイト、βリン酸三カルシウム、セラミックス、複合材料、骨形成タンパク質（BMP）、脱灰骨マトリックス、その他）、用途別、エンドユーザー別、地域別
  • 世界のオーソバイオロジクス市場2022-2029：製品タイプ別（粘液サプリメント、骨成長因子、脱灰骨マトリックス（DBM）、合成骨代替物、細胞移植片、同種移植片、その他）、用途別、エンドユーザー別、地域別
  • 世界の組織工学市場（～2028年）：製品別（スキャフォールド（コラーゲン、幹細胞）、組織移植片（同種移植片、自家移植片、異種移植片））、材料別（生物学的、合成）、用途別（整形外科、皮膚科、創傷治療、心臓血管）
  • 世界の整形外科用骨移植片代替品市場予測2023-2029：骨形成タンパク質（BMP）、合成骨移植片、その他
  • 世界の骨間隙充填剤市場2022-2029：種類別（脱灰骨マトリックス、リン酸カルシウム骨移植片代替品、コラーゲンマトリックス、その他）、形態別、用途別、エンドユーザー別、地域別
  • 世界の骨移植＆骨代用材市場2024-2030：材料タイプ別（同種移植片、合成）、用途別（頭蓋顎顔面、歯科）、地域別
  • 世界の骨移植＆代替骨市場2021年-2031年：種類別（同種移植片、代替骨、細胞基質）、用途別（脊椎固定、外傷、関節再建、歯科骨移植、頭蓋顎顔面）、エンドユーザー別（病院、専門医院、その他）

    • ◆H&Iグローバルリサーチのお客様（例）◆